Announcements Trials

Browse Landscape

Status

Completed 5 Unknown 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Cancer, Papillary 1

Interventions

pembrolizumab 563 Specimen Handling 493 Carboplatin 451 Magnetic Resonance Spectroscopy 444 Cyclophosphamide 418 Cisplatin 405 Radiotherapy 353 Bevacizumab 314 Gemcitabine 313 Paclitaxel 298 Biopsy 292 Drug Therapy 284 Blood Specimen Collection 248 Capecitabine 246 Oxaliplatin 241 fludarabine 239 Nivolumab 234 venetoclax 221 Injections 213 Docetaxel 211 Fluorouracil 206 Dexamethasone 188 Radiosurgery 182 Standard of Care 159 Rituximab 159 Pemetrexed 156 Surgical Procedures, Operative 148 atezolizumab 146 durvalumab 145 Leucovorin 140

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Genotype × Clear all

NCT05766098 2024-10-08

PTC-ARRAY

Istituto Auxologico Italiano

EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡